This topic contains a solution. Click here to go to the answer

Author Question: A producer is said to have a comparative advantage in the production of a good when: A) the ... (Read 132 times)

burchfield96

  • Hero Member
  • *****
  • Posts: 610
A producer is said to have a comparative advantage in the production of a good when:
 
  A) the producer has a higher opportunity cost than another producer.
  B) the producer can produce more units of the good per hour than another producer.
  C) the producer has a lower opportunity cost than another producer.
  D) the producer charges a higher price for the good than the other producers.

Question 2

If the consumption function is C = 90 + 0.75y, then the level of autonomous consumption is
 
  A) 0.25. B) 0.75. C) 67.5. D) 90.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tandmlomax84

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

C

Answer to Question 2

D





 

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library